BNP Paribas Financial Markets’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9K Sell
7,822
-2,146
-22% -$8.79K ﹤0.01% 5097
2026
Q1
$43.1K Sell
9,968
-35
-0.3% -$173 ﹤0.01% 4773
2025
Q4
$58.1K Sell
10,003
-145
-1% -$694 ﹤0.01% 4611
2025
Q3
$38.9K Buy
10,148
+3,478
+52% +$13.3K ﹤0.01% 4699
2025
Q2
$23.9K Buy
6,670
+5,600
+523% +$15.9K ﹤0.01% 4522
2025
Q1
$2.72K Sell
1,070
-58
-5% -$215 ﹤0.01% 4942
2024
Q4
$4.34K Buy
+1,128
New +$3.66K ﹤0.01% 4946

Other funds holding KRMD

BNP Paribas Financial Markets's KRMD Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its KORU Medical Systems (KRMD) stake by 22% in Q2 2026, selling an estimated $8.79K and leaving 7,822 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5097.

BNP Paribas Financial Markets first reported a position in KRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $58.1K in Q4 2025. 80 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • BNP Paribas Financial Markets held 7,822 shares of KORU Medical Systems worth $32.9K as of Q2 2026.
  • BNP Paribas Financial Markets sold 2,146 KORU Medical Systems shares in Q2 2026, an estimated $8.79K.
  • KORU Medical Systems made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5097 holding.
  • BNP Paribas Financial Markets first reported a position in KORU Medical Systems in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's KORU Medical Systems position peaked at $58.1K in Q4 2025.
  • 80 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.